Respiratory Medicine
Volume 100, Issue 11 , Pages 1973-1980 , November 2006

Chronic respiratory symptoms, spirometry and knowledge of COPD among general population

  • Marc Miravitlles

      Affiliations

    • Servei de Pneumologia, Institut Clínic del Tòrax (IDIBAPS), Hospital Clinic, Barcelona, Catalonia, Spain
    • Corresponding Author InformationCorresponding author. Tel./fax: +34932275549.
    • ,
  • Cristian de la Roza

      Affiliations

    • Servei de Pneumologia, Institut Clínic del Tòrax (IDIBAPS), Hospital Clinic, Barcelona, Catalonia, Spain
    • ,
  • Josep Morera

      Affiliations

    • Servei de Pneumologia, Hospital Germans Trias i Pujol, Badalona, Catalonia, Spain
    • ,
  • Teodoro Montemayor

      Affiliations

    • Servicio de Neumología, Hospital Virgen del Rocío, Sevilla, Spain
    • ,
  • Elena Gobartt

      Affiliations

    • R&D Department Boehringer Ingelheim, Spain
    • ,
  • Antonio Martín

      Affiliations

    • R&D Department Pfizer, Spain
    • ,
  • José Luis Alvarez-Sala

      Affiliations

    • Servicio de Neumología, Hospital Clínico San Carlos, Madrid, Spain

Received 5 September 2005 ,Accepted 24 February 2006.

References 

  1. Mannino DM, Brown C, Giovino GA. Obstructive lung disease deaths in the United States from 1979 through 1993: an analysis using multiple-cause mortality data. Am J Respir Crit Care Med. 1997;156:814–818
  2. Miravitlles M, Murio C, Guerrero T, Gisbert R on behalf of the DAFNE study group. Costs of chronic bronchitis and COPD: a one year follow-up study. Chest. 2003;123:784–791
  3. Hilleman DE, Dewan N, Malesker M, Friedman M. Pharmacoeconomic evaluation of COPD. Chest. 2000;118:1278–1285
  4. Miravitlles M, Figueras M. El coste de la enfermedad pulmonar obstructiva crónica en España: Opciones para una optimización de recursos. Arch Bronconeumol. 2001;37:388–393
  5. Masa JF, Sobradillo V, Villasante C, et al. Costs of chronic obstructive pulmonary disease in Spain: estimation from a population-based study. Arch Bronconeumol. 2004;40:72–79
  6. Sobradillo Pena V, Miravitlles M, Gabriel R, et al. Geographical variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest. 2000;118:981–989
  7. Coultas DB, Mapel D, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med. 2001;164:372–377
  8. Renwick DS, Connolly MJ. Prevalence and treatment of chronic airways obstruction in adults over the age of 45. Thorax. 1996;51:164–168
  9. Rennard S, Decramer M, Calverley PM, et al. Impact of COPD in North America and Europe in 2000: subjects’ perspective of Confronting COPD International Survey. Eur Respir J. 2002;20:799–805
  10. Potthoff RF. Telephone sampling in epidemiologic research: to reap the benefits, avoid the pitfalls. Am J Epidemiol. 1994;139:967–978
  11. Minette A. Questionnaire of the European Community for Coal and Steel (ECSC) on respiratory symptoms: 1987—updating of the 1962 and 1967 questionnaires for studying chronic bronchitis and emphysema. Eur Respir J. 1989;2:165–177
  12. Pena SV, Miravitlles M, Jimenez CA, et al. Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation. Arch Bronconeumol. 1999;35:159–166
  13. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581–586
  14. von Hertzen L, Reunanen A, Impivaara O, Mälkiä E, Aromaa A. Airway obstruction in relation to symptoms in chronic respiratory disease—a nationally representative population study. Respir Med. 2000;94:356–363
  15. Montnemery P, Adelroth E, Heuman K, et al. Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden. Respir Med. 1998;92:1337–1345
  16. Huchon GJ, Vergnenègre A, Neukirch F, Brami G, Roche N, Preux PM. Chronic bronchitis among French adults: high prevalence and underdiagnosis. Eur Respir J. 2002;20:806–812
  17. Naberan Toña C. Encuesta de la actitud terapéutica y de control de los médicos generales de las ABS de Barcelona, respecto a enfermedades obstructivas respiratorias. Aten Primaria (Barc). 1994;13:112–115
  18. De Miguel Díez J, Izquierdo Alonso JL, Molina París J, Rodríguez González-Moro JM, de Lucas Ramos P, Gaspar Alonso-Vega G. Reliability of chronic obstructive pulmonary disease diagnosis by primary care physicians and pneumologists in Spain. Predictive factors. Arch Bronconeumol. 2003;39:203–208
  19. Clotet J, Gómez-Arbonés X, Ciria C, Albalad JM. Spirometry is a good method for detecting and monitoring chronic obstructive pulmonary disease in high-risk smokers in primary health care. Arch Bronconeumol. 2004;40:155–159
  20. Miravitlles M, Fernández I, Guerrero T, Murio C. The development and efficacy of a primary care screening program for chronic obstructive pulmonary disease: the PADOC project. Arch Bronconeumol. 2000;36:500–505
  21. Zielinski J, Bednarek M. Early detection of COPD in a high-risk population using spirometric screening. Chest. 2001;119:731–736
  22. Miravitlles M, Ferrer M, Pont A, et al. Characteristics of a population of COPD patients identified from a population-based study: focus on previous diagnosis and never smokers. Respir Med. 2005;99:985–995
  23. Miravitlles M, de la Roza C, Naberan K, et al. Attitudes towards the diagnosis of chronic obstructive pulmonary disease in primary care. Arch Bronconeumol. 2006;42:3–8
  24. Jimenez-Ruiz CA, Masa F, Miravitlles M, et al. Smoking characteristics: attitudes and dependence: differences between healthy smokers and smokers with COPD. Chest. 2001;119:1365–1370

PII: S0954-6111(06)00109-0

doi: 10.1016/j.rmed.2006.02.024

Respiratory Medicine
Volume 100, Issue 11 , Pages 1973-1980 , November 2006

Article Tools

* Image Usage & Resolution